These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 8562031)

  • 41. Cycline-dependent kinase inhibitor, p27 (KIP1), is associated with cholesteatoma.
    Bayazít YA; Karakök M; Uçak R; Kanlíkama M
    Laryngoscope; 2001 Jun; 111(6):1037-41. PubMed ID: 11404617
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Platelet-derived growth factor in middle ear cholesteatoma.
    Fujioka O; Huang CC
    Eur Arch Otorhinolaryngol; 1994; 251(4):199-204. PubMed ID: 7917251
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role of Langerhans cells, Ki-67 protein and apoptosis in acquired cholesteatoma: prospective clinical study.
    Akdogan V; Yilmaz I; Canpolat T; Ozluoglu LN
    J Laryngol Otol; 2013 Mar; 127(3):252-9. PubMed ID: 23331470
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inflammatory cell subpopulations in chronic otitis media. The Langerhans' cells.
    Palva T; Taskinen E
    Arch Otolaryngol Head Neck Surg; 1987 Feb; 113(2):149-54. PubMed ID: 3541970
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expression patterns of cytokeratins in cholesteatomas: evidence of increased migration and proliferation.
    Kim HJ; Tinling SP; Chole RA
    J Korean Med Sci; 2002 Jun; 17(3):381-8. PubMed ID: 12068144
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In search of missing links in otology. III. Development of a new animal model for cholesteatoma.
    Hueb MM; Goycoolea MV; Muchow D; Duvall AJ; Paparella MM; Sheridan C
    Laryngoscope; 1993 Jul; 103(7):774-84. PubMed ID: 8341103
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Acquired and congenital cholesteatoma: determination of tumor necrosis factor-alpha, intercellular adhesion molecule-1, interleukin-1-alpha and lymphocyte functional antigen-1 in the inflammatory process.
    Akimoto R; Pawankar R; Yagi T; Baba S
    ORL J Otorhinolaryngol Relat Spec; 2000; 62(5):257-65. PubMed ID: 10965261
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The pathogenesis of acquired cholesteatoma of the human middle ear: support for the migration hypothesis.
    Karmody CS; Northrop C
    Otol Neurotol; 2012 Jan; 33(1):42-7. PubMed ID: 22143292
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Spatial distribution of Langerhans' cells and T-lymphocyte subpopulations in human tympanic membrane and aural cholesteatoma.
    van Dijk CM; Visser CE; Veldman JE
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1986; 52(2):143-52. PubMed ID: 2878530
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [New aspects on the pathogenesis of cholesteatoma: the possible role of immune cell-induced keratinocyte hyperproliferation].
    Bujía J; Holly A; Kim C; Schilling V; Kastenbauer E
    Laryngorhinootologie; 1993 Jun; 72(6):279-83. PubMed ID: 8333881
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lymphotoxin in human middle ear cholesteatoma.
    Yan SD; Huang CC
    Laryngoscope; 1991 Apr; 101(4 Pt 1):411-5. PubMed ID: 1680210
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [A study on the state of cell proliferation and apoptosis in human middle ear cholesteatoma].
    Yu Q; Jin K
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2001 Oct; 15(10):450-1. PubMed ID: 12541689
    [TBL] [Abstract][Full Text] [Related]  

  • 53. L1CAM-ILK-YAP Mechanotransduction Drives Proliferative Activity of Epithelial Cells in Middle Ear Cholesteatoma.
    Yamamoto-Fukuda T; Akiyama N; Kojima H
    Am J Pathol; 2020 Aug; 190(8):1667-1679. PubMed ID: 32360569
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Markers of epidermal proliferation in middle ear cholesteatoma].
    Hassmann-Poznańska E; Skotnicka B; Dziecioł J
    Otolaryngol Pol; 2003; 57(4):505-11. PubMed ID: 14587387
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunohistochemical analysis of the cytokeratin expression in middle ear cholesteatoma and related epithelial tissues.
    Broekaert D; Coucke P; Leperque S; Ramaekers F; Van Muijen G; Boedts D; Leigh I; Lane B
    Ann Otol Rhinol Laryngol; 1992 Nov; 101(11):931-8. PubMed ID: 1280020
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunohistochemical study on proliferative activity of experimental cholesteatoma.
    Park K; Park HJ; Chun YM
    Eur Arch Otorhinolaryngol; 2001 Mar; 258(3):101-5. PubMed ID: 11374247
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Increased numbers of mast cells in human middle ear cholesteatomas: implications for treatment.
    Albino AP; Reed JA; Bogdany JK; Sassoon J; Parisier SC
    Am J Otol; 1998 May; 19(3):266-72. PubMed ID: 9596172
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Proliferation activity and apoptosis in granulation tissue and cholesteatoma in middle ear reoperations.
    Durko M; Kaczmarczyk D
    Folia Morphol (Warsz); 2004 Feb; 63(1):119-21. PubMed ID: 15039916
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [A study on expression of tumor necrosis factor alpha in middle ear cholesteatoma and its effect on bone destruction].
    Li Z; Li X; Liu G
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2001 Feb; 15(2):66-7. PubMed ID: 12541866
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Possible role of interleukin 1 alpha and interleukin 1 beta in the pathogenesis of cholesteatoma of the middle ear.
    Schilling V; Negri B; Bujía J; Schulz P; Kastenbauer E
    Am J Otol; 1992 Jul; 13(4):350-5. PubMed ID: 1384343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.